NCT02047305 - Radiofrequency Ablation for Patients With Esophageal Squamous Cell Neoplasia | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

January 31, 2009

Primary Completion Date

August 31, 2016

Study Completion Date

November 30, 2016

Conditions

ESOPHAGEAL SQUAMOUS CELL CARCINOMA

Interventions

DEVICE

Radiofrequency Ablation

Patients with a histopathological diagnosis of moderate-grade intra-epithelial neoplasia (MGIN), high-grade intra-epithelial neoplasia (HGIN) and/or early flat-type SCCA of the esophagus, are treated with radiofrequency ablation, with repeat endoscopy and follow-up treatment at 3 month intervals.

Trial Locations (1)

100021

Cancer Institute and Hospital, Chinese Academy of Medical Sciences, Beijing